Melanie Lee received an undergraduate degree in Biology from the University of York and then a Ph.D. at National Institute for Medical Research in London. She is Chief Scientific Officer at BTG plc since November 2014, a company which operates in interventional medicine in vascular disease, oncology and pulmonology. She worked as a molecular genetics postdoc, first at Imperial College London on y...